Recurrent thrombophlebitis in association with CHOEP-14.
Bjarnason
N H
NH
Jurlander
J
J
Dalhoff
K
K
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000009:adverse effects; D004317:Doxorubicin / Q000009:adverse effects; D005047:Etoposide / Q000009:adverse effects; D005260:Female; D006801:Humans; D008224:Lymphoma, Follicular / Q000150:complications / Q000188:drug therapy*; D008875:Middle Aged; D011239:Prednisolone / Q000009:adverse effects; D012008:Recurrence; D013924:Thrombophlebitis / Q000139:chemically induced* / Q000175:diagnosis; D013997:Time Factors; D014750:Vincristine / Q000009:adverse effects
D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone